These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3276779)

  • 21. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
    Hirose T
    Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
    J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
    Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C
    Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro production of anti-DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE patients.
    Cairns E; St Germain J; Bell DA
    J Immunol; 1985 Dec; 135(6):3839-44. PubMed ID: 3905965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.
    Clark EA; Shu G
    J Immunol; 1987 Feb; 138(3):720-5. PubMed ID: 3492530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.
    Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R
    Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.
    Tanaka Y; Saito K; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
    J Immunol; 1988 Nov; 141(9):3043-9. PubMed ID: 3262675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T; Leiserson WM; Asofsky R
    J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density.
    Suzuki N; Ueda Y; Sakane T
    J Clin Invest; 1988 Jan; 81(1):261-9. PubMed ID: 2826542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells.
    Sterkers G; Henin Y; Kalil J; Bagot M; Levy JP
    J Immunol; 1983 Dec; 131(6):2735-40. PubMed ID: 6227663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
    Kanda N; Watanabe S
    J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of polyclonal B-cell activity in systemic lupus erythematosus.
    Levinson AI; Dziarski A; Pincus T; deHoratius RJ; Zweiman B
    J Clin Lab Immunol; 1981 Jan; 5(1):17-22. PubMed ID: 6971331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of autologous reactive helper T lymphocytes for differentiation of human B lymphocytes.
    Shin HS; Wang CY; Choi YS
    J Immunol; 1981 Jun; 126(6):2485-9. PubMed ID: 7014720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls.
    Jacobi AM; Goldenberg DM; Hiepe F; Radbruch A; Burmester GR; Dörner T
    Ann Rheum Dis; 2008 Apr; 67(4):450-7. PubMed ID: 17673490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.